Uday S Gogate
Bristol-Myers Squibb
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Uday S Gogate.
Pharmaceutical Development and Technology | 2009
Uday S Gogate; Philip A. Schwartz; Shreeram Agharkar
Taxol for Injection Concentrate contains a solution of paclitaxel in a 50:50 v/v mixture of Cremophor EL (cleaned):ethanol. Cleaned, rather than unpurified, Cremophor EL is used as a cosolvent because paclitaxel was observed to be less stable in the presence of unpurified Cremophor. In order to understand the cause of this paclitaxel instability, various studies were performed. The results of these studies, coupled with the examination of degradation products, suggested that carboxylate anions present in the unpurified Cremophor catalyze the degradation of paclitaxel by general base catalyzed ethanolysis. Stabilization of Taxol for Injection Concentrate prepared with unpurified Cremophor can be achieved by addition of strong acids, resulting in neutralization of the carboxylate anions. Separately, a quality control test for the cleaning procedure of Cremophor is needed to insure stability of Taxol for Injection Concentrate. A colorimetric indicator test was identified which can distinguish between good and poor quality cleaned Cremophor as it pertains to paclitaxel stability.
Archive | 1994
Shreeram Agharkar; Uday S Gogate
Archive | 2009
Munir N. Nassar; Uday S Gogate; Timothy M. Malloy
Archive | 2006
Munir N. Nassar; Uday S Gogate; Timothy M. Malloy
Archive | 1994
Shreerham Narahari Agharkar; Uday S Gogate; Thomas Cavanak
Archive | 1996
Uday S Gogate; Shreeram Agharkar; Lawan Phusanti
Archive | 2006
Munir N. Nassar; Uday S Gogate; Timothy M. Malloy
Archive | 2006
Munir N. Nassar; Uday S Gogate; Timothy M. Malloy
Archive | 1996
Uday S Gogate; William Francis Light; Shreeram Narahari Agharkar
Archive | 1994
Shreerham Narahari Agharkar; Uday S Gogate; Thomas Cavanak